1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Feng, Y.
Klein, B.K.
Mcwherter, C.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
259
524
541
10.1006/jmbi.1996.0337
8676386
Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3.
1996
US
Biochemistry
BICHAW
0033
0006-2960
34
6540
1H, 13C, and 15N NMR Resonance Assignments, Secondary Structure, and Backbone Topology of a Variant of Human Interleukin-3
1995
10.2210/pdb1jli/pdb
pdb_00001jli
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12844.856
INTERLEUKIN 3
DEL(1-13), V14A, N18I, T25H, Q29R, L32N, F37P, G42S, Q45M, N51R, R55T, E59L, N62V, S67H, Q69E, DEL(126-133)
1
man
polymer
MULTI-CSF
no
no
ANCSIMIDEIIHHLKRPPNPLLDPNNLNSEDMDILMERNLRTPNLLAFVRAVKHLENASAIESILKNLLPCLPLATAAPT
RHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQ
ANCSIMIDEIIHHLKRPPNPLLDPNNLNSEDMDILMERNLRTPNLLAFVRAVKHLENASAIESILKNLLPCLPLATAAPT
RHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
JM101
PMON 13302
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-06-16
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1995-12-14
REL
REL
1
AS IN X-PLOR PARALLHDG.PRO STRUCTURES WERE CALCULATED USING A SIMULATED ANNEALING PROTOCOL IN X-PLOR. INPUT CONSTRAINTS ARE AS FOLLOWS: 1659 NUCLEAR OVERHAUSER ENHANCEMENT (NOE) (799 INTRA-RESIDUE; 342 SEQUENTIAL (I-J =1); 236 MEDIUM-RANGE INTERRESIDUE (<1 I-J <=5); 282 LONG-RANGE INTERRESIDUE (I-J >5)); 38 PAIRS OF HYDROGEN-BOND RESTRAINTS; 76 PHI TORSION ANGLE RESTRAINTS. PSEUDOATOM POSITIONS WERE USED FOR CONSTRAINTS INVOLVING METHYLENE, AROMATIC, AND METHYL PROTONS. THE COORDINATES DEPOSITED HERE ARE OBTAINED BY AVERAGING 25 CONVERGED STRUCTURES PRIOR TO A RESTRAINED ENERGY MINIMIZATION. A COMPARISON OF THE FAMILY OF THE 25 STRUCTURES WITH THE AVERAGED STRUCTURE GIVES RMSD VALUES OF 0.88 ANGSTROMS FOR ALL (N,CA,C') EXCEPT RESIDUES 28 - 39, AND 0.41 ANGSTROMS FOR (N,CA,C') OF HELICAL REGIONS (RESIDUES 16 - 26, 42 - 49, 54 - 67, 72 - 84, AND 104 - 122).
BRUNGER
refinement
X-PLOR
3.1
ALA
14
n
1
ALA
14
A
ASN
15
n
2
ASN
15
A
CYS
16
n
3
CYS
16
A
SER
17
n
4
SER
17
A
ILE
18
n
5
ILE
18
A
MET
19
n
6
MET
19
A
ILE
20
n
7
ILE
20
A
ASP
21
n
8
ASP
21
A
GLU
22
n
9
GLU
22
A
ILE
23
n
10
ILE
23
A
ILE
24
n
11
ILE
24
A
HIS
25
n
12
HIS
25
A
HIS
26
n
13
HIS
26
A
LEU
27
n
14
LEU
27
A
LYS
28
n
15
LYS
28
A
ARG
29
n
16
ARG
29
A
PRO
30
n
17
PRO
30
A
PRO
31
n
18
PRO
31
A
ASN
32
n
19
ASN
32
A
PRO
33
n
20
PRO
33
A
LEU
34
n
21
LEU
34
A
LEU
35
n
22
LEU
35
A
ASP
36
n
23
ASP
36
A
PRO
37
n
24
PRO
37
A
ASN
38
n
25
ASN
38
A
ASN
39
n
26
ASN
39
A
LEU
40
n
27
LEU
40
A
ASN
41
n
28
ASN
41
A
SER
42
n
29
SER
42
A
GLU
43
n
30
GLU
43
A
ASP
44
n
31
ASP
44
A
MET
45
n
32
MET
45
A
ASP
46
n
33
ASP
46
A
ILE
47
n
34
ILE
47
A
LEU
48
n
35
LEU
48
A
MET
49
n
36
MET
49
A
GLU
50
n
37
GLU
50
A
ARG
51
n
38
ARG
51
A
ASN
52
n
39
ASN
52
A
LEU
53
n
40
LEU
53
A
ARG
54
n
41
ARG
54
A
THR
55
n
42
THR
55
A
PRO
56
n
43
PRO
56
A
ASN
57
n
44
ASN
57
A
LEU
58
n
45
LEU
58
A
LEU
59
n
46
LEU
59
A
ALA
60
n
47
ALA
60
A
PHE
61
n
48
PHE
61
A
VAL
62
n
49
VAL
62
A
ARG
63
n
50
ARG
63
A
ALA
64
n
51
ALA
64
A
VAL
65
n
52
VAL
65
A
LYS
66
n
53
LYS
66
A
HIS
67
n
54
HIS
67
A
LEU
68
n
55
LEU
68
A
GLU
69
n
56
GLU
69
A
ASN
70
n
57
ASN
70
A
ALA
71
n
58
ALA
71
A
SER
72
n
59
SER
72
A
ALA
73
n
60
ALA
73
A
ILE
74
n
61
ILE
74
A
GLU
75
n
62
GLU
75
A
SER
76
n
63
SER
76
A
ILE
77
n
64
ILE
77
A
LEU
78
n
65
LEU
78
A
LYS
79
n
66
LYS
79
A
ASN
80
n
67
ASN
80
A
LEU
81
n
68
LEU
81
A
LEU
82
n
69
LEU
82
A
PRO
83
n
70
PRO
83
A
CYS
84
n
71
CYS
84
A
LEU
85
n
72
LEU
85
A
PRO
86
n
73
PRO
86
A
LEU
87
n
74
LEU
87
A
ALA
88
n
75
ALA
88
A
THR
89
n
76
THR
89
A
ALA
90
n
77
ALA
90
A
ALA
91
n
78
ALA
91
A
PRO
92
n
79
PRO
92
A
THR
93
n
80
THR
93
A
ARG
94
n
81
ARG
94
A
HIS
95
n
82
HIS
95
A
PRO
96
n
83
PRO
96
A
ILE
97
n
84
ILE
97
A
HIS
98
n
85
HIS
98
A
ILE
99
n
86
ILE
99
A
LYS
100
n
87
LYS
100
A
ASP
101
n
88
ASP
101
A
GLY
102
n
89
GLY
102
A
ASP
103
n
90
ASP
103
A
TRP
104
n
91
TRP
104
A
ASN
105
n
92
ASN
105
A
GLU
106
n
93
GLU
106
A
PHE
107
n
94
PHE
107
A
ARG
108
n
95
ARG
108
A
ARG
109
n
96
ARG
109
A
LYS
110
n
97
LYS
110
A
LEU
111
n
98
LEU
111
A
THR
112
n
99
THR
112
A
PHE
113
n
100
PHE
113
A
TYR
114
n
101
TYR
114
A
LEU
115
n
102
LEU
115
A
LYS
116
n
103
LYS
116
A
THR
117
n
104
THR
117
A
LEU
118
n
105
LEU
118
A
GLU
119
n
106
GLU
119
A
ASN
120
n
107
ASN
120
A
ALA
121
n
108
ALA
121
A
GLN
122
n
109
GLN
122
A
ALA
123
n
110
ALA
123
A
GLN
124
n
111
GLN
124
A
GLN
125
n
112
GLN
125
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ASN
15
-150.16
53.31
1
A
LEU
27
-113.24
56.50
1
A
LYS
28
-158.44
68.20
1
A
PRO
31
-77.64
-73.22
1
A
ASN
38
-54.05
88.80
1
A
ALA
90
2.77
66.28
1
A
ALA
91
-177.16
143.39
1
A
THR
93
-150.48
-45.85
1
A
PRO
96
-78.18
-164.52
1
A
ILE
97
-67.86
-171.86
1
A
LYS
100
-119.46
-161.46
1
A
TYR
114
-68.06
-84.58
1
A
ALA
123
-123.60
-74.56
1
A
GLN
124
59.93
94.96
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
HUMAN INTERLEUKIN 3 (IL-3) MUTANT WITH TRUNCATION AT BOTH N-AND C-TERMINI AND 14 RESIDUE CHANGES, NMR, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
CYS
16
A
CYS
3
HELX_P
A
HIS
26
A
HIS
13
1
1
11
A
SER
42
A
SER
29
HELX_P
A
MET
49
A
MET
36
1
2
8
A
ARG
54
A
ARG
41
HELX_P
A
HIS
67
A
HIS
54
1
3
14
A
SER
72
A
SER
59
HELX_P
A
CYS
84
A
CYS
71
1
4
13
A
TRP
104
A
TRP
91
HELX_P
A
GLN
122
A
GLN
109
1
5
19
disulf
2.021
A
CYS
16
A
SG
CYS
3
1_555
A
CYS
84
A
SG
CYS
71
1_555
CYTOKINE
HEMATOPOIETIC GROWTH FACTOR, COLONY-STIMULATING FACTOR, CYTOKINE
IL3_HUMAN
UNP
1
1
P08700
MSRLPVLLLLQLLVRPGLQAPMTQTTPLKTSWVNCSNMIDEIITHLKQPPLPLLDFNNLNGEDQDILMENNLRRPNLEAF
NRAVKSLQNASAIESILKNLLPCLPLATAAPTRHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQTTLSLAIF
34
144
1JLI
15
125
P08700
A
1
2
112
1
ASN
engineered mutation
ILE
18
1JLI
A
P08700
UNP
37
5
1
THR
engineered mutation
HIS
25
1JLI
A
P08700
UNP
44
12
1
GLN
engineered mutation
ARG
29
1JLI
A
P08700
UNP
48
16
1
LEU
engineered mutation
ASN
32
1JLI
A
P08700
UNP
51
19
1
PHE
engineered mutation
PRO
37
1JLI
A
P08700
UNP
56
24
1
GLY
engineered mutation
SER
42
1JLI
A
P08700
UNP
61
29
1
GLN
engineered mutation
MET
45
1JLI
A
P08700
UNP
64
32
1
ASN
engineered mutation
ARG
51
1JLI
A
P08700
UNP
70
38
1
ARG
engineered mutation
THR
55
1JLI
A
P08700
UNP
74
42
1
GLU
engineered mutation
LEU
59
1JLI
A
P08700
UNP
78
46
1
ASN
engineered mutation
VAL
62
1JLI
A
P08700
UNP
81
49
1
SER
engineered mutation
HIS
67
1JLI
A
P08700
UNP
86
54
1
GLN
engineered mutation
GLU
69
1JLI
A
P08700
UNP
88
56
1
P 1